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Spinal cord schistosomiasis is a rare, underdiagnosed manifestation of schistosomiasis. We present the case of a 36-year-old male
who presented to our institution with a one-week history of low back pain with rapidly progressive lower limb weakness, loss of
sensation, and flaccid paraparesis. An MRI of the spine showed a longitudinally extensive transverse myelitis from T6 to L1, with
enhancement at the cauda equina region. Further review of the images and serological tests eventually led to diagnosis of spinal
schistosomiasis. He was treated with praziquantel and high-dose steroids, with minimal improvement in his symptoms.
1. Introduction
According to the World Health Organization, in 2018, 229
million individuals were estimated to be suffering from
schistosomiasis. Schistosomiasis is endemic in 78 countries
worldwide. In Kenya, approximately 3 million individuals
require preventive chemotherapy for schistosomiasis an-
nually [1]. Schistosomiasis accounts for 1 to 4 percent of
spinal cord lesions in sub-Saharan Africa. +e prevalence of
oviposition in the spinal cord varies among studies, ranging
from 0.3% to 13% [2]. +e clinical presentation of spinal
cord schistosomiasis (SCS) is heterogeneous but often
presents with low back pain and lower limb weakness
sometimes affecting ambulation. Other symptoms include
bladder dysfunction, lower limb paraesthesia, hypoesthesia
or anaesthesia, deep tendon reflex abnormalities (hyper-,
hypo-, or areflexia), constipation, and sexual impotence [2].
SCS usually presents acutely or subacutely and is classified
into three clinical forms: medullary with a predominance of
spinal cord involvement, myeloradicular, with mainly spinal
cord and nerve root involvement, and conus-cauda equina
syndrome, with predominantly conus or cauda equina in-
volvement [2–4]. +e diagnosis of SCS is based upon the
presentation of neurological symptoms resulting from le-
sions of the spinal cord, the demonstration of schistosomal
infection using microscopy and serological techniques, and
the exclusion of other causes of myelopathy [4, 5]. Treatment
usually includes antischistosomal drugs with corticosteroids
[2, 4–6].
2. Case
A 36-year-old male from central region of Kenya presented
to our institution with a 3-day history of back pain, followed
by itching and numbness of the feet and ankles. On pre-
sentation, his symptoms had progressed to weakness of the
lower limbs with inability to walk and he had developed
urinary incontinence. He denied speech and swallowing
difficulties and reported no weakness of the upper limbs.+e
patient reported no history of fevers, blurred vision, loss of
consciousness, or seizure. He also denied a history of
trauma, use of blood thinners, use of illicit drugs (including
tobacco and alcohol use), a history of exposure to tuber-
culosis, or ingestion of raw milk. He did report swimming in
a nearby pond for many years. His family history was un-
remarkable, and he was an only child.
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On examination, he had normal vital signs and was
conscious and alert. A neurological exam revealed normal
cranial nerves. Visual field was also preserved. Exami-
nation of both his upper limbs was normal. He had
tenderness of the lower back, power grade 4/5 on hip
flexors and extensors bilaterally, grade 4/5 and 2/5 on the
right and left knee extensors, respectively, and power
grade 3/5 and 1/5 on the right and left knee flexors, re-
spectively, and dorsiflexion was grade 1/5 bilaterally. A
knee jerk reflex was present on his right lower extremity
but reduced on the left. Ankle reflexes were absent bi-
laterally. Sensory level was present at L2.
His complete blood count and a comprehensive meta-
bolic panel were within normal limits. A lumbar puncture
revealed a protein count of 0.97 g/l (0.15–0.45 g/l), with a
pleocytosis of 35mm3(normal <5). A differential count
showed 30% of segmented neutrophils and 70% of lym-
phocytes. Monocytes, eosinophils, and basophils were ab-
sent. +e glucose level was normal. Cultures of the
cerebrospinal fluids, including for tuberculosis, were neg-
ative. Serological test for HIV, herpes virus, and syphilis was
also negative. An autoimmune screen including ANA, anti-
ds DNA, and ENA was negative. A vasculitis screen and
serum angiotensin-converting enzyme were also reported as
normal.
His thyroid stimulating hormone, vitamin B12, and
folate level were all within normal limits.
An MRI of the spine showed longitudinally extensive
transverse myelitis (T2 hyper intense intramedullary signal
spanning T6-L1 with enhancement) (Figures 1–3).
Based on his MRI results and clinical symptoms, neu-
romyelitis optica (NMO) was high on the differential di-
agnosis. He was initiated on high-dose steroids,
methylprednisone one gram intravenously for 5 days.
However, his neurological status continued to decline. Five
sessions of therapeutic plasma exchange were also attempted
with no improvement in his symptoms. Serum and CSF
neuromyelitis antibodies and oligoclonal bands as well as
serum MOG antibodies (myelin oligodendrocyte glyco-
protein) were later reported as negative.
A few days into his hospitalization, his Schistosoma
antibody (IgG) titer was reported at at 1 : 80. A subsequent
liver ultrasound was reported as normal. He was immedi-
ately started on praziquantel at 60mg/kg/dose and high-
dose steroids with minimal improvement in his overall
symptoms. He was discharged home with recommendations
for home care and aggressive physical therapy.
3. Discussion
Schistosoma mansoni and Schistosoma haematobium are the
most common causes of spinal schistosomiasis [2]. Spinal
schistosomiasis usually presents as symptoms of spinal cord
compression, transverse myelopathy, and painful lumbo-
sacral radiculopathy with low back pain or cauda equina or
conus medullaris syndrome [4, 6–9].
Infections like tuberculosis or herpes viruses can present
with conus lesions. Inflammatory, vascular, and demyelin-
ating diseases such as multiple sclerosis and neuromyelitis
optica can also present in a similar fashion, mostly affecting
the cervical and mid-thoracic spine. Spinal cord schisto-
somiasis differs from the other conditions in that it pre-
dominantly affects the lower spinal cord.
In our patient, the diagnosis of spinal schistosomiasis
was based on the prevalence of Schistosoma in Kenya, his
neurological findings, imaging results, Schistosoma titers,
and exclusion of other causes of spinal cord diseases [10].
Even though there was no evidence of hepatosplenic
schistosomiasis nor any evidence of schistosomal eggs in
urine and faecal samples, this is usually not sufficient to rule
out schistosomiasis [2, 10].
Cerebrospinal fluid examination usually shows slight-to-
moderate increases in both total protein concentration and
lymphocytic count. Eosinophils can present in the CSF in
about 50% of patients. A prospective study of 63 patients
with schistosomal myeloradiculopathy done in Brazil
revealed high total protein concentration in CSF and or
Figure 1: T2 lumbar sagittal, abnormal high signal at the cauda
equina.
Figure 2: T2 sagittal hyperintense intramedullary signal from T6 to
conus medullaris.
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pleocytosis in the great majority (95.2%) of the cases [3]. A
little more than half (57.4%) of the 63 cases presented with
eosinophils in the CSF. In our patient, CSF analysis reflected
an inflammatory pattern characterized by increase in the
total protein concentration and pleocytosis. Eosinophils
were not found.
Enlargement of the lower thoracic spinal cord, swelling
of the conus medullaris, and thickening of spinal roots that
form the cauda equina are some of the findings on an MRI.
Furthermore, high-intensity signal on T2-weighted se-
quence and heterogeneous enhancement of gadolinium
contrast on T1-weighted sequence can be observed in the
acute spinal neuroschistosomiasis [2, 5, 10].
A definitive diagnosis of spinal schistosomiasis would
require biopsy of the lesion which is associated with po-
tential serious consequences like worsening of neurological
signs and symptoms [2]. Due to the risks involved, our
patient opted out of a biopsy.
No specific clinical picture is pathognomonic of spinal
schistosomiasis. However, conus and cauda syndrome with
intramedullary lesion in an endemic area should raise the
suspicion of schistosomiasis [2, 3, 11].
Treatment with praziquantel and steroids is associated
with clinical improvement, even when started late in the
course of the disease [5]. Significant improvement was
observed in lumbar and lower limb pain, urinary and in-
testinal dysfunction, lower limb strength, and ambulation
within the first twomonths of therapy [5]. Some studies have
shown that early treatment is better than late treatment [3].
Once treatment is initiated, the outcome of SCS is good
[3, 5, 10].
Management of SCS is multidisciplinary and involves
the participation of various professionals including nurses,
physiotherapists, general clinicians, neurologists,
psychologists, and occupational therapists. Physiotherapy
remains key for patients with impaired motor functions and
must be maintained even after the termination of cortico-
steroid therapy [10]. In our patient, a follow-up visit 3
months later showed improved bilateral plantar and dor-
siflexion of his lower extremities with power grade 2/5 with
plantar and dorsiflexion. However, he had power grade 2/5
on hip flexors and extensors bilaterally, grade 2/5 on the
bilateral knee extensors respectively, and power grade 1/5 on
the bilateral knee flexors.
4. Conclusion
Spinal schistosomiasis is a rare manifestation of schistoso-
miasis. Definitive diagnosis of spinal cord schistosomiasis is
made by detection of the eggs in a spinal cord biopsy or at
autopsy. However, a presumptive diagnosis can be made
from involvement of the lower spinal cord especially the
conus medullaris and cauda equina, suggestive clinical
picture, and history or evidence of active schistosomiasis.
Exclusion of other conditions is also essential for diagnosis.
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